A clinical evaluation of safety of combination therapy with Rapid Onset Opioid and Short Acting Opioid.
Phase 4
- Conditions
- Cancer Pain
- Registration Number
- JPRN-UMIN000019224
- Lead Sponsor
- Kansai Electric Power Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. the hypersensitiveness to opioids 2. serious respiratory depression or serious chronic obstructive pulmonary disease 3. disturbance of consciousness or the lack of judgment ability 4. gastrointestinal obstruction 5. not applicable determined by the attending physician responsible for the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Analgesic effects (NRS, STAS-J) Adverse effect rate
- Secondary Outcome Measures
Name Time Method Efficacy rate